The Israel Competition Authority (ICA) conducted a thorough investigation of the S. Schestowitz Group, an Israeli company in the food and consumer goods sector, due to suspicions the company operated a cartel in the food...more
7/17/2025
/ Antitrust Investigations ,
Antitrust Violations ,
Breach of Competition Law ,
Cartels ,
Consumer Product Companies ,
Criminal Investigations ,
Criminal Prosecution ,
Enforcement Actions ,
Enforcement Priorities ,
Evidence ,
Food Manufacturers ,
Indictments ,
Investigations ,
Israel ,
Obstruction of Justice ,
Pharmaceutical Industry ,
Popular
Bank Hapoalim and Israel Discount Bank will each pay the State Treasury ILS 40 million within the framework of an administrative settlement (“agreed order”), in respect of their acquisitions of minority stakes in a competitor...more
5/8/2025
/ Acquisitions ,
Antitrust Provisions ,
Antitrust Violations ,
Banking Sector ,
Banks ,
Breach of Competition Law ,
Competition ,
Enforcement Actions ,
Financial Institutions ,
Israel ,
Minority Shareholders ,
Penalties ,
Regulatory Oversight ,
Settlement
The Israeli Competition Director General recently announced he had reached an agreement with the British pharmaceutical company Leadiant Biosciences. According to the agreement, Leadiant undertook to pay ILS 110,000 to the...more
The Competition Director General has issued a precedent-setting determination against the pharmaceutical marketing company MBI Pharma Ltd. (MBI). The Director General determined that MBI abused its monopolistic position and...more
1/23/2023
/ Anti-Competitive ,
Competition Authorities ,
Corporate Fines ,
Drug Pricing ,
Enforcement Actions ,
Excessive Pricing ,
Israel ,
Ministry of Health ,
Monopolization ,
Pharmaceutical Industry ,
Prescription Drugs ,
Unfair Competition